Correlation Between Bristol Myers and Business Development

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Business Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Business Development into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Business Development Corp, you can compare the effects of market volatilities on Bristol Myers and Business Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Business Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Business Development.

Diversification Opportunities for Bristol Myers and Business Development

0.65

Correlation Coefficient

Bristol Myers  Business Development

Poor diversification

The 3 months correlation between Bristol and Business is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Business Development Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Business Development Corp and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Business Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Business Development Corp has no effect on the direction of Bristol Myers i.e., Bristol Myers and Business Development go up and down completely randomly.

Pair Corralation between Bristol Myers and Business Development

Assuming the 90 days horizon Bristol Myers Squibb is expected to under-perform the Business Development. In addition to that, Bristol Myers is 99.97 times more volatile than Business Development Corp. It trades about 0.0 of its total potential returns per unit of risk. Business Development Corp is currently generating about 0.22 per unit of volatility. If you would invest  1,000.00  in Business Development Corp on September 20, 2024 and sell it today you would earn a total of  1.00  from holding Business Development Corp or generate 0.1% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	95.45%
Values	Daily Returns

Bristol Myers Squibb  vs.  Business Development Corp

Bristol Myers Squibb

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol Myers reported solid returns over the last few months and may actually be approaching a breakup point.

Business Development Corp

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Business Development Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Business Development is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Bristol Myers and Business Development

The main advantage of trading using opposite Bristol Myers and Business Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Business Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Business Development will offset losses from the drop in Business Development's long position.

The idea behind Bristol Myers Squibb and Business Development Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.